The global Pet Veterinary Drug market was valued at US$ 8714.7 million in 2023 and is anticipated to reach US$ 12120 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.

Pet Veterinary Drug Market

Pet Veterinary Drug refers to a drug used in the diagnosis, cure, mitigation, treatment or prevention of diseases in pets.

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 47%.

This report aims to provide a comprehensive presentation of the global market for Pet Veterinary Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Veterinary Drug.

Report Scope

The Pet Veterinary Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Veterinary Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pet Veterinary Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pet Veterinary Drug Market Report

Report Metric	Details
Report Name	Pet Veterinary Drug Market
Accounted market size in 2023	US$ 8714.7 million
Forecasted market size in 2030	US$ 12120 million
CAGR	4.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Anti-Infectives Anti-Inflammatory Parasiticides Analgesics Sedatives Others
Segment by Application	Veterinary Hospitals Veterinary Clinics Drug Stores
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Boehringer Ingelheim International GmbH, Zoetis Animal Healthcare, Bayer AG, Merck Animal Health, Elanco Animal Health Inc., Virbac Group, Ceva, Dechra Pharmaceuticals Plc, Vetoquinol, Orion Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Veterinary Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Veterinary Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pet Veterinary Drug Market growing?

Ans: The Pet Veterinary Drug Market witnessing a CAGR of 4.9% during the forecast period 2024-2030.

What is the Pet Veterinary Drug Market size in 2030?

Ans: The Pet Veterinary Drug Market size in 2030 will be US$ 12120 million.

Who are the main players in the Pet Veterinary Drug Market report?

Ans: The main players in the Pet Veterinary Drug Market are Boehringer Ingelheim International GmbH, Zoetis Animal Healthcare, Bayer AG, Merck Animal Health, Elanco Animal Health Inc., Virbac Group, Ceva, Dechra Pharmaceuticals Plc, Vetoquinol, Orion Corporation

What are the Application segmentation covered in the Pet Veterinary Drug Market report?

Ans: The Applications covered in the Pet Veterinary Drug Market report are Veterinary Hospitals, Veterinary Clinics, Drug Stores

What are the Type segmentation covered in the Pet Veterinary Drug Market report?

Ans: The Types covered in the Pet Veterinary Drug Market report are Anti-Infectives, Anti-Inflammatory, Parasiticides, Analgesics, Sedatives, Others

1 Pet Veterinary Drug Market Overview

1.1 Product Overview and Scope of Pet Veterinary Drug

1.2 Pet Veterinary Drug Segment by Type

1.2.1 Global Pet Veterinary Drug Market Value Comparison by Type (2024-2030)

1.2.2 Anti-Infectives

1.2.3 Anti-Inflammatory

1.2.4 Parasiticides

1.2.5 Analgesics

1.2.6 Sedatives

1.2.7 Others

1.3 Pet Veterinary Drug Segment by Application

1.3.1 Global Pet Veterinary Drug Market Value by Application: (2024-2030)

1.3.2 Veterinary Hospitals

1.3.3 Veterinary Clinics

1.3.4 Drug Stores

1.4 Global Pet Veterinary Drug Market Size Estimates and Forecasts

1.4.1 Global Pet Veterinary Drug Revenue 2019-2030

1.4.2 Global Pet Veterinary Drug Sales 2019-2030

1.4.3 Global Pet Veterinary Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Pet Veterinary Drug Market Competition by Manufacturers

2.1 Global Pet Veterinary Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global Pet Veterinary Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Pet Veterinary Drug Average Price by Manufacturers (2019-2024)

2.4 Global Pet Veterinary Drug Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pet Veterinary Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pet Veterinary Drug, Product Type & Application

2.7 Pet Veterinary Drug Market Competitive Situation and Trends

2.7.1 Pet Veterinary Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Pet Veterinary Drug Players Market Share by Revenue

2.7.3 Global Pet Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pet Veterinary Drug Retrospective Market Scenario by Region

3.1 Global Pet Veterinary Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Pet Veterinary Drug Global Pet Veterinary Drug Sales by Region: 2019-2030

3.2.1 Global Pet Veterinary Drug Sales by Region: 2019-2024

3.2.2 Global Pet Veterinary Drug Sales by Region: 2025-2030

3.3 Global Pet Veterinary Drug Global Pet Veterinary Drug Revenue by Region: 2019-2030

3.3.1 Global Pet Veterinary Drug Revenue by Region: 2019-2024

3.3.2 Global Pet Veterinary Drug Revenue by Region: 2025-2030

3.4 North America Pet Veterinary Drug Market Facts & Figures by Country

3.4.1 North America Pet Veterinary Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Pet Veterinary Drug Sales by Country (2019-2030)

3.4.3 North America Pet Veterinary Drug Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pet Veterinary Drug Market Facts & Figures by Country

3.5.1 Europe Pet Veterinary Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Pet Veterinary Drug Sales by Country (2019-2030)

3.5.3 Europe Pet Veterinary Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pet Veterinary Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Pet Veterinary Drug Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Pet Veterinary Drug Sales by Country (2019-2030)

3.6.3 Asia Pacific Pet Veterinary Drug Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Pet Veterinary Drug Market Facts & Figures by Country

3.7.1 Latin America Pet Veterinary Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Pet Veterinary Drug Sales by Country (2019-2030)

3.7.3 Latin America Pet Veterinary Drug Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pet Veterinary Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Pet Veterinary Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Pet Veterinary Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa Pet Veterinary Drug Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Pet Veterinary Drug Sales by Type (2019-2030)

4.1.1 Global Pet Veterinary Drug Sales by Type (2019-2024)

4.1.2 Global Pet Veterinary Drug Sales by Type (2025-2030)

4.1.3 Global Pet Veterinary Drug Sales Market Share by Type (2019-2030)

4.2 Global Pet Veterinary Drug Revenue by Type (2019-2030)

4.2.1 Global Pet Veterinary Drug Revenue by Type (2019-2024)

4.2.2 Global Pet Veterinary Drug Revenue by Type (2025-2030)

4.2.3 Global Pet Veterinary Drug Revenue Market Share by Type (2019-2030)

4.3 Global Pet Veterinary Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global Pet Veterinary Drug Sales by Application (2019-2030)

5.1.1 Global Pet Veterinary Drug Sales by Application (2019-2024)

5.1.2 Global Pet Veterinary Drug Sales by Application (2025-2030)

5.1.3 Global Pet Veterinary Drug Sales Market Share by Application (2019-2030)

5.2 Global Pet Veterinary Drug Revenue by Application (2019-2030)

5.2.1 Global Pet Veterinary Drug Revenue by Application (2019-2024)

5.2.2 Global Pet Veterinary Drug Revenue by Application (2025-2030)

5.2.3 Global Pet Veterinary Drug Revenue Market Share by Application (2019-2030)

5.3 Global Pet Veterinary Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Boehringer Ingelheim International GmbH

6.1.1 Boehringer Ingelheim International GmbH Corporation Information

6.1.2 Boehringer Ingelheim International GmbH Description and Business Overview

6.1.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Portfolio

6.1.5 Boehringer Ingelheim International GmbH Recent Developments/Updates

6.2 Zoetis Animal Healthcare

6.2.1 Zoetis Animal Healthcare Corporation Information

6.2.2 Zoetis Animal Healthcare Description and Business Overview

6.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Zoetis Animal Healthcare Pet Veterinary Drug Product Portfolio

6.2.5 Zoetis Animal Healthcare Recent Developments/Updates

6.3 Bayer AG

6.3.1 Bayer AG Corporation Information

6.3.2 Bayer AG Description and Business Overview

6.3.3 Bayer AG Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Bayer AG Pet Veterinary Drug Product Portfolio

6.3.5 Bayer AG Recent Developments/Updates

6.4 Merck Animal Health

6.4.1 Merck Animal Health Corporation Information

6.4.2 Merck Animal Health Description and Business Overview

6.4.3 Merck Animal Health Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Merck Animal Health Pet Veterinary Drug Product Portfolio

6.4.5 Merck Animal Health Recent Developments/Updates

6.5 Elanco Animal Health Inc.

6.5.1 Elanco Animal Health Inc. Corporation Information

6.5.2 Elanco Animal Health Inc. Description and Business Overview

6.5.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Elanco Animal Health Inc. Pet Veterinary Drug Product Portfolio

6.5.5 Elanco Animal Health Inc. Recent Developments/Updates

6.6 Virbac Group

6.6.1 Virbac Group Corporation Information

6.6.2 Virbac Group Description and Business Overview

6.6.3 Virbac Group Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Virbac Group Pet Veterinary Drug Product Portfolio

6.6.5 Virbac Group Recent Developments/Updates

6.7 Ceva

6.6.1 Ceva Corporation Information

6.6.2 Ceva Description and Business Overview

6.6.3 Ceva Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Ceva Pet Veterinary Drug Product Portfolio

6.7.5 Ceva Recent Developments/Updates

6.8 Dechra Pharmaceuticals Plc

6.8.1 Dechra Pharmaceuticals Plc Corporation Information

6.8.2 Dechra Pharmaceuticals Plc Description and Business Overview

6.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Portfolio

6.8.5 Dechra Pharmaceuticals Plc Recent Developments/Updates

6.9 Vetoquinol

6.9.1 Vetoquinol Corporation Information

6.9.2 Vetoquinol Description and Business Overview

6.9.3 Vetoquinol Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Vetoquinol Pet Veterinary Drug Product Portfolio

6.9.5 Vetoquinol Recent Developments/Updates

6.10 Orion Corporation

6.10.1 Orion Corporation Corporation Information

6.10.2 Orion Corporation Description and Business Overview

6.10.3 Orion Corporation Pet Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Orion Corporation Pet Veterinary Drug Product Portfolio

6.10.5 Orion Corporation Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pet Veterinary Drug Industry Chain Analysis

7.2 Pet Veterinary Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pet Veterinary Drug Production Mode & Process

7.4 Pet Veterinary Drug Sales and Marketing

7.4.1 Pet Veterinary Drug Sales Channels

7.4.2 Pet Veterinary Drug Distributors

7.5 Pet Veterinary Drug Customers

8 Pet Veterinary Drug Market Dynamics

8.1 Pet Veterinary Drug Industry Trends

8.2 Pet Veterinary Drug Market Drivers

8.3 Pet Veterinary Drug Market Challenges

8.4 Pet Veterinary Drug Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim International GmbH

Zoetis Animal Healthcare

Bayer

Merck Animal Health

Elanco Animal Health Inc.

Virbac Group

Ceva

Dechra Pharmaceuticals Plc

Vetoquinol

Orion Corporation

List of Tables

Table 1. Global Pet Veterinary Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Pet Veterinary Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Pet Veterinary Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global Pet Veterinary Drug Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Pet Veterinary Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Pet Veterinary Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Pet Veterinary Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Pet Veterinary Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Pet Veterinary Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pet Veterinary Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pet Veterinary Drug, Product Type & Application

Table 12. Global Key Manufacturers of Pet Veterinary Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pet Veterinary Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Veterinary Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pet Veterinary Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Pet Veterinary Drug Sales by Region (2019-2024) & (K Units)

Table 18. Global Pet Veterinary Drug Sales Market Share by Region (2019-2024)

Table 19. Global Pet Veterinary Drug Sales by Region (2025-2030) & (K Units)

Table 20. Global Pet Veterinary Drug Sales Market Share by Region (2025-2030)

Table 21. Global Pet Veterinary Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Pet Veterinary Drug Revenue Market Share by Region (2019-2024)

Table 23. Global Pet Veterinary Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Pet Veterinary Drug Revenue Market Share by Region (2025-2030)

Table 25. North America Pet Veterinary Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Pet Veterinary Drug Sales by Country (2019-2024) & (K Units)

Table 27. North America Pet Veterinary Drug Sales by Country (2025-2030) & (K Units)

Table 28. North America Pet Veterinary Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Pet Veterinary Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Pet Veterinary Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Pet Veterinary Drug Sales by Country (2019-2024) & (K Units)

Table 32. Europe Pet Veterinary Drug Sales by Country (2025-2030) & (K Units)

Table 33. Europe Pet Veterinary Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Pet Veterinary Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Pet Veterinary Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Pet Veterinary Drug Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Pet Veterinary Drug Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Pet Veterinary Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Pet Veterinary Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Pet Veterinary Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Pet Veterinary Drug Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Pet Veterinary Drug Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Pet Veterinary Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Pet Veterinary Drug Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Pet Veterinary Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Pet Veterinary Drug Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Pet Veterinary Drug Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Pet Veterinary Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Pet Veterinary Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Pet Veterinary Drug Sales (K Units) by Type (2019-2024)

Table 51. Global Pet Veterinary Drug Sales (K Units) by Type (2025-2030)

Table 52. Global Pet Veterinary Drug Sales Market Share by Type (2019-2024)

Table 53. Global Pet Veterinary Drug Sales Market Share by Type (2025-2030)

Table 54. Global Pet Veterinary Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Pet Veterinary Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Pet Veterinary Drug Revenue Market Share by Type (2019-2024)

Table 57. Global Pet Veterinary Drug Revenue Market Share by Type (2025-2030)

Table 58. Global Pet Veterinary Drug Price (USD/Unit) by Type (2019-2024)

Table 59. Global Pet Veterinary Drug Price (USD/Unit) by Type (2025-2030)

Table 60. Global Pet Veterinary Drug Sales (K Units) by Application (2019-2024)

Table 61. Global Pet Veterinary Drug Sales (K Units) by Application (2025-2030)

Table 62. Global Pet Veterinary Drug Sales Market Share by Application (2019-2024)

Table 63. Global Pet Veterinary Drug Sales Market Share by Application (2025-2030)

Table 64. Global Pet Veterinary Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Pet Veterinary Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Pet Veterinary Drug Revenue Market Share by Application (2019-2024)

Table 67. Global Pet Veterinary Drug Revenue Market Share by Application (2025-2030)

Table 68. Global Pet Veterinary Drug Price (USD/Unit) by Application (2019-2024)

Table 69. Global Pet Veterinary Drug Price (USD/Unit) by Application (2025-2030)

Table 70. Boehringer Ingelheim International GmbH Corporation Information

Table 71. Boehringer Ingelheim International GmbH Description and Business Overview

Table 72. Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Boehringer Ingelheim International GmbH Pet Veterinary Drug Product

Table 74. Boehringer Ingelheim International GmbH Recent Developments/Updates

Table 75. Zoetis Animal Healthcare Corporation Information

Table 76. Zoetis Animal Healthcare Description and Business Overview

Table 77. Zoetis Animal Healthcare Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Zoetis Animal Healthcare Pet Veterinary Drug Product

Table 79. Zoetis Animal Healthcare Recent Developments/Updates

Table 80. Bayer AG Corporation Information

Table 81. Bayer AG Description and Business Overview

Table 82. Bayer AG Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Bayer AG Pet Veterinary Drug Product

Table 84. Bayer AG Recent Developments/Updates

Table 85. Merck Animal Health Corporation Information

Table 86. Merck Animal Health Description and Business Overview

Table 87. Merck Animal Health Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Merck Animal Health Pet Veterinary Drug Product

Table 89. Merck Animal Health Recent Developments/Updates

Table 90. Elanco Animal Health Inc. Corporation Information

Table 91. Elanco Animal Health Inc. Description and Business Overview

Table 92. Elanco Animal Health Inc. Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Elanco Animal Health Inc. Pet Veterinary Drug Product

Table 94. Elanco Animal Health Inc. Recent Developments/Updates

Table 95. Virbac Group Corporation Information

Table 96. Virbac Group Description and Business Overview

Table 97. Virbac Group Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Virbac Group Pet Veterinary Drug Product

Table 99. Virbac Group Recent Developments/Updates

Table 100. Ceva Corporation Information

Table 101. Ceva Description and Business Overview

Table 102. Ceva Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Ceva Pet Veterinary Drug Product

Table 104. Ceva Recent Developments/Updates

Table 105. Dechra Pharmaceuticals Plc Corporation Information

Table 106. Dechra Pharmaceuticals Plc Description and Business Overview

Table 107. Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Dechra Pharmaceuticals Plc Pet Veterinary Drug Product

Table 109. Dechra Pharmaceuticals Plc Recent Developments/Updates

Table 110. Vetoquinol Corporation Information

Table 111. Vetoquinol Description and Business Overview

Table 112. Vetoquinol Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Vetoquinol Pet Veterinary Drug Product

Table 114. Vetoquinol Recent Developments/Updates

Table 115. Orion Corporation Corporation Information

Table 116. Orion Corporation Description and Business Overview

Table 117. Orion Corporation Pet Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Orion Corporation Pet Veterinary Drug Product

Table 119. Orion Corporation Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Pet Veterinary Drug Distributors List

Table 123. Pet Veterinary Drug Customers List

Table 124. Pet Veterinary Drug Market Trends

Table 125. Pet Veterinary Drug Market Drivers

Table 126. Pet Veterinary Drug Market Challenges

Table 127. Pet Veterinary Drug Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Pet Veterinary Drug

Figure 2. Global Pet Veterinary Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Pet Veterinary Drug Market Share by Type in 2023 & 2030

Figure 4. Anti-Infectives Product Picture

Figure 5. Anti-Inflammatory Product Picture

Figure 6. Parasiticides Product Picture

Figure 7. Analgesics Product Picture

Figure 8. Sedatives Product Picture

Figure 9. Others Product Picture

Figure 10. Global Pet Veterinary Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Pet Veterinary Drug Market Share by Application in 2023 & 2030

Figure 12. Veterinary Hospitals

Figure 13. Veterinary Clinics

Figure 14. Drug Stores

Figure 15. Global Pet Veterinary Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Pet Veterinary Drug Market Size (2019-2030) & (US$ Million)

Figure 17. Global Pet Veterinary Drug Sales (2019-2030) & (K Units)

Figure 18. Global Pet Veterinary Drug Average Price (USD/Unit) & (2019-2030)

Figure 19. Pet Veterinary Drug Report Years Considered

Figure 20. Pet Veterinary Drug Sales Share by Manufacturers in 2023

Figure 21. Global Pet Veterinary Drug Revenue Share by Manufacturers in 2023

Figure 22. The Global 5 and 10 Largest Pet Veterinary Drug Players: Market Share by Revenue in 2023

Figure 23. Pet Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 24. Global Pet Veterinary Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 25. North America Pet Veterinary Drug Sales Market Share by Country (2019-2030)

Figure 26. North America Pet Veterinary Drug Revenue Market Share by Country (2019-2030)

Figure 27. U.S. Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Canada Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Europe Pet Veterinary Drug Sales Market Share by Country (2019-2030)

Figure 30. Europe Pet Veterinary Drug Revenue Market Share by Country (2019-2030)

Figure 31. Germany Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. France Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. U.K. Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Italy Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Russia Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Pet Veterinary Drug Sales Market Share by Region (2019-2030)

Figure 37. Asia Pacific Pet Veterinary Drug Revenue Market Share by Region (2019-2030)

Figure 38. China Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Japan Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. South Korea Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. India Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Australia Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Taiwan Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Indonesia Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Thailand Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Malaysia Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Philippines Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Latin America Pet Veterinary Drug Sales Market Share by Country (2019-2030)

Figure 49. Latin America Pet Veterinary Drug Revenue Market Share by Country (2019-2030)

Figure 50. Mexico Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Brazil Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Argentina Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Middle East & Africa Pet Veterinary Drug Sales Market Share by Country (2019-2030)

Figure 54. Middle East & Africa Pet Veterinary Drug Revenue Market Share by Country (2019-2030)

Figure 55. Turkey Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. U.A.E Pet Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. Global Sales Market Share of Pet Veterinary Drug by Type (2019-2030)

Figure 59. Global Revenue Market Share of Pet Veterinary Drug by Type (2019-2030)

Figure 60. Global Pet Veterinary Drug Price (USD/Unit) by Type (2019-2030)

Figure 61. Global Sales Market Share of Pet Veterinary Drug by Application (2019-2030)

Figure 62. Global Revenue Market Share of Pet Veterinary Drug by Application (2019-2030)

Figure 63. Global Pet Veterinary Drug Price (USD/Unit) by Application (2019-2030)

Figure 64. Pet Veterinary Drug Value Chain

Figure 65. Pet Veterinary Drug Production Process

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Distributors Profiles

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions